Filing Details

Accession Number:
0001883850-21-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-04 16:10:49
Reporting Period:
2021-10-01
Accepted Time:
2021-10-04 16:10:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187443 F Arthur Ryan 777 Old Saw Mill River Road
Tarrytown NY 10591
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-10-01 1 $560.51 23,290 No 4 S Direct
Common Stock Disposition 2021-10-01 4 $562.68 23,286 No 4 S Direct
Common Stock Disposition 2021-10-01 3 $563.84 23,283 No 4 S Direct
Common Stock Disposition 2021-10-01 12 $564.47 23,271 No 4 S Direct
Common Stock Disposition 2021-10-01 11 $565.36 23,260 No 4 S Direct
Common Stock Disposition 2021-10-01 10 $566.65 23,250 No 4 S Direct
Common Stock Disposition 2021-10-01 1 $567.99 23,249 No 4 S Direct
Common Stock Disposition 2021-10-01 1 $568.03 23,248 No 4 S Direct
Common Stock Disposition 2021-10-01 15 $569.54 23,233 No 4 S Direct
Common Stock Disposition 2021-10-01 9 $570.37 23,224 No 4 S Direct
Common Stock Disposition 2021-10-01 2 $571.88 23,222 No 4 S Direct
Common Stock Disposition 2021-10-01 1 $572.32 23,221 No 4 S Direct
Common Stock Disposition 2021-10-01 7 $573.54 23,214 No 4 S Direct
Common Stock Disposition 2021-10-01 5 $574.33 23,209 No 4 S Direct
Common Stock Disposition 2021-10-01 4 $575.41 23,205 No 4 S Direct
Common Stock Disposition 2021-10-01 12 $576.34 23,193 No 4 S Direct
Common Stock Disposition 2021-10-01 2 $577.27 23,191 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 4 shares of Company stock on October 1, 2021 at prices ranging from $562.05 to $562.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price.
  3. Represents volume-weighted average price of sales of 3 shares of Company stock on October 1, 2021 at prices ranging from $563.54 to $563.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price.
  4. Represents volume-weighted average price of sales of 12 shares of Company stock on October 1, 2021 at prices ranging from $564.15 to $564.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price.
  5. Represents volume-weighted average price of sales of 11 shares of Company stock on October 1, 2021 at prices ranging from $565.00 to $565.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price.
  6. Represents volume-weighted average price of sales of 10 shares of Company stock on October 1, 2021 at prices ranging from $566.10 to $566.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price.
  7. Represents volume-weighted average price of sales of 15 shares of Company stock on October 1, 2021 at prices ranging from $569.07 to $569.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price.
  8. Represents volume-weighted average price of sales of 9 shares of Company stock on October 1, 2021 at prices ranging from $570.00 to $570.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price.
  9. Represents volume-weighted average price of sales of 2 shares of Company stock on October 1, 2021 at prices ranging from $571.81 to $571.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price.
  10. Represents volume-weighted average price of sales of 7 shares of Company stock on October 1, 2021 at prices ranging from $573.00 to $573.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price.
  11. Represents volume-weighted average price of sales of 5 shares of Company stock on October 1, 2021 at prices ranging from $574.00 to $574.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price.
  12. Represents volume-weighted average price of sales of 4 shares of Company stock on October 1, 2021 at prices ranging from $575.18 to $575.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price.
  13. Represents volume-weighted average price of sales of 12 shares of Company stock on October 1, 2021 at prices ranging from $576.00 to $576.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price.
  14. Represents volume-weighted average price of sales of 2 shares of Company stock on October 1, 2021 at prices ranging from $577.09 to $577.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price.